Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dipak P. Mali, Dinanath T. Gaikwad, Manish S. Bhatia & Neela M. Bhatia. (2022) Discovery of pyridoindole derivatives as potential inhibitors for phosphodiesterase 5A: in silico and in vivo studies. Natural Product Research 36:11, pages 2767-2776.
Read now
Read now
Dipak Pralhad Mali & Neela Manish Bhatia. (2021) Discovery of two novel hetero-tricyclic lead scaffolds as PDE5A inhibitor: virtual screening, molecular docking and pharmacophore modeling approach. Natural Product Research 35:1, pages 92-98.
Read now
Read now
Articles from other publishers (4)
Abduladheem Turki Jalil, Maysoon Mohammed Hassan, Rand Ali Ziyad, Ihsan Jasim, Rahman Zabibah & Ali Fadhil. (2023) PDE5 inhibitors and gastric mucosa: implications for the management of peptic ulcer disease. Naunyn-Schmiedeberg's Archives of Pharmacology 396:10, pages 2261-2267.
Crossref
Crossref
Ahmed K. ElHady, Dalia S. El-Gamil, Mohammad Abdel-Halim & Ashraf H. Abadi. (2023) Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives. Pharmaceuticals 16:9, pages 1266.
Crossref
Crossref
Dipak P. Mali & Neela M. Bhatia. (2019) Hetero-Tricyclic Lead Scaffold as Novel PDE5A Inhibitor for Antihypertensive Activity: In Silico Docking Studies. Current Computer-Aided Drug Design 15:4, pages 318-333.
Crossref
Crossref
Vesna Rastija, Harshad Brahmbhatt, Maja Molnar, Melita Lončarić, Ivica Strelec, Mario Komar & Valentina Pavić. (2019) Synthesis, Tyrosinase Inhibiting Activity and Molecular Docking of Fluorinated Pyrazole Aldehydes as Phosphodiesterase Inhibitors. Applied Sciences 9:8, pages 1704.
Crossref
Crossref